Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fibronectin (FN) polymorphism is caused by alternative splicing patterns in at least three regions (ED-A,
ED-B
and IIICS) of the primary transcript of a single gene. Using monoclonal antibodies, we previously demonstrated that transforming growth factor-beta (TGF-beta) preferentially increases the accumulation of the FN isoforms containing the ED-A sequence in cultured normal human fibroblasts [Balza et al., (1988) FEBS Lett. 228, 42-44]. To determine the basis of this effect, we have examined through
S1 nuclease
analysis, the levels of ED-A- and
ED-B
-containing mRNAs in cultured normal human skin fibroblasts before and after TGF-beta treatment. These experiments have shown that TGF-beta increases the relative amount of m-RNA for ED-A- and
ED-B
-containing FN isoforms. These data demonstrate that a growth factor may regulate the splicing pattern of a pre-mRNA.
...
PMID:Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. 230 31